Philip C. Hogan - Concepedia

Author

Philip C. Hogan

Harvard University

Also Known As

Hogan, P.C., Philip C Hogan, Philip C. Hogan, Philip Hogan

Publications

458

Citations

H-Index

Concepts

All Affiliations

Harvard University Tetraphase Pharmaceuticals (United States)Harvard University Press

About

Philip C. Hogan is an author at Harvard University specializing in natural sciences, pharmacology, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	8	8	305
2	Biochemistry	6	6	228
3	Engineering	5	5	137
4	Medicine	4	4	213
5	Allergy	1	1	71

Philip C. Hogan

Publications

449

Citations

H-Index

Page 1

	Year	Citations
Proteasome Inhibition by a Totally Synthetic β-Lactam Related to Salinosporamide A and Omuralide Philip C. Hogan, E. J. Corey Journal of the American Chemical Society Molecular PharmacologyMedicinal ChemistryProteasome InhibitionBioorganic ChemistryBiochemistry	2005	73
Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy Roger B. Clark, Diana K. Hunt, Minsheng He, Journal of Medicinal Chemistry Medicinal ChemistryAllergyAntibioticsMedicineAntibacterial Activity	2011	71
Kedarcidin Chromophore: Synthesis of Its Proposed Structure and Evidence for a Stereochemical Revision Feng Ren, Philip C. Hogan, Alan J. Anderson, Journal of the American Chemical Society Combinatorial ChemistryBiosynthesisBioorganic ChemistryProposed StructureBiochemistry	2007	70
Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development Magnus Rönn, Zhijian Zhu, Philip C. Hogan, Organic Process Research & Development Pharmaceutical ScienceOrganic ChemistryPharmacotherapyAntimicrobial ChemotherapyPre-clinical Pharmacology	2013	59
Enantioselective Synthesis of Kedarcidin Chromophore Aglycon in Differentially Protected Form Andrew G. Myers, Philip C. Hogan, Alexander R. Hurd, Angewandte Chemie International Edition Combinatorial ChemistryMedicinal ChemistryTransannular Anionic CyclizationHeterocyclicEnantioselective Synthesis	2002	50
Evidence for Facile Atropisomerism and Simple (Non-Nucleophilic) Biradical-Forming Cycloaromatization within Kedarcidin Chromophore Aglycon Andrew G. Myers, Alexander R. Hurd, Philip C. Hogan Journal of the American Chemical Society	2002	24
Large-scale preparation of key building blocks for the manufacture of fully synthetic macrolide antibiotics Philip C. Hogan, Chi-Li Chen, Kristen M Mulvihill, The Journal of Antibiotics Combinatorial ChemistryKey Building BlocksEngineeringAntibiotic AdjuvantLarge-scale Preparation	2017	24
Process Research and Development of an Enantiomerically Enriched Allyic Amine, One of the Key Intermediates for the Manufacture of Synthetic Tetracyclines Wu‐Yan Zhang, Philip C. Hogan, Chi-Li Chen, Organic Process Research & Development EngineeringOrganic ChemistryChemistryMedicinal ChemistryAvailable Dimethyl Maleate	2015	18
Synthesis and Biological Evaluation of 8-Aminomethyltetracycline Derivatives as Novel Antibacterial Agents Roger B. Clark, Minsheng He, Yonghong Deng, Journal of Medicinal Chemistry	2013	14
Synthesis of <scp>l</scp>-Kedarosamine in Protected Form and Its Efficient Incorporation into an Advanced Intermediate to Kedarcidin Chromophore Feng Ren, Philip C. Hogan, Alan J. Anderson, Organic Letters Combinatorial ChemistryBioorganic ChemistryEngineeringOrganic ChemistryChemistry	2007	13

Page 1